Interferon-γ-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 118 (2) , 250-264
- https://doi.org/10.1016/0008-8749(89)90376-6
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleenImmunology Today, 1987
- Interferon: a cytotoxic T lymphocyte differentiation signalEuropean Journal of Immunology, 1986
- In VivoAugmentation of Natural Killer Activity by Combined Treatment with Recombinant Gamma Interferon and Interleukin-2Journal of Interferon Research, 1985
- γ-Interferon is one of several direct B cell-maturing lymphokinesNature, 1984
- Gamma‐interferon (IFN‐γ) produced during effector and target interactions renders target cells less susceptible to NK‐cell‐mediated lysisInternational Journal of Cancer, 1983
- Interferon-lnduced resistance to the killing by NK cells: A preferential effect of IFN-γCellular Immunology, 1983
- Production of gamma interferon by human T and null cells and its regulation by macrophagesCellular Immunology, 1982
- Preparative separation of human T cells reactive with the OKT4 monoclonal antibodyInternational Journal of Immunopharmacology, 1981
- Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.The Journal of Experimental Medicine, 1978
- Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic systemNature, 1974